COVID-19: NCDC confirms 574 new cases, dismisses 1,478 patients

The National Agency for the Development of Primary Health Care (NPHCDA) said it plans to vaccinate approximately 109 million Nigerians who qualify for vaccination against COVID-19 over two years.

Executive Director, NPHCDA, dr. Faisal Shuaib, announced in the Presidential Working Group (PTF) at a briefing on COVID-19, on Monday, in Abuja.

“We still expect about 57 million doses of COVID-19 vaccines from COVAX Facility and AU. Working with states, the federal government plans to vaccinate all eligible populations aged eighteen and older, including pregnant women.

“However, the decision to vaccinate any pregnant woman will be made in agreement with her doctor. The question of whether there is a risk of infecting Covid-19 or not will be considered.

“She will probably be exposed to great risk, for example, if the health worker is in the first place, support staff or the first person to react in various spheres of the security architecture of our country.”

“These guidelines are based on the Strategic Advisory Group of Immunization Experts (SAGE). “After excluding those under the age of 18, we plan to vaccinate approximately 109 million Nigerians who will be eligible for COVID-19 vaccination in two years,” he said.

Shuaib said the federal government had additionally committed 1,500,000 and 100,000 doses of AstraZeneca from MTN and the Indian government, respectively.

“These eligible populations have been identified using the World Health Organization (WHO), vaccine allocation frameworks and roadmaps for prioritization, as well as disease burden data from the Nigerian Center for Disease Control (NCDC).

“They are the first health workers, support staff; including those working in high-risk areas such as incoming workers, rapid response teams, contact search teams, COVID-19 vaccination teams and strategic leadership; people older than 50 and older and people aged 18 to 49, with significant simultaneous morbidities and additional risk groups, “he said.

Source